Aleena Banerji Selected Research

Angioedema

7/2022	Urticaria and/or angioedema secondary to mRNA COVID-19 vaccines: Updates from a United States case registry.
7/2021	Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study.
10/2020	Association Between Self-Reported Dental Hygiene Practices and Dental Procedure-Related Recurrent Angioedema Attacks in HAE Subjects: A Multicenter Survey.
10/2020	Patient Characteristics and Concerns about Drug Allergy: A Report from the United States Drug Allergy Registry.
1/2019	Advances in drug allergy, urticaria, angioedema, and anaphylaxis in 2018.
1/2019	Identification of Inpatient Allergic Drug Reactions Using ICD-9-CM Codes.
9/2018	Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema.
7/2017	Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema.
5/2017	Epidemiology of ACE Inhibitor Angioedema Utilizing a Large Electronic Health Record.
1/2017	Emergency Department Management of Hereditary Angioedema Attacks: Patient Perspectives.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aleena Banerji Research Topics

Disease

46	Hypersensitivity (Allergy) 01/2022 - 07/2007
24	Hereditary Angioedemas 03/2022 - 01/2008
20	Angioedema 07/2022 - 11/2006
19	Anaphylaxis (Anaphylactic Shock) 01/2022 - 11/2007
9	Drug Hypersensitivity (Drug Allergy) 01/2021 - 07/2014
8	COVID-19 01/2022 - 01/2021
5	Urticaria (Hives) 07/2022 - 07/2014
5	Drug-Related Side Effects and Adverse Reactions 11/2019 - 01/2015
5	Asthma (Bronchial Asthma) 01/2019 - 12/2005
5	Immediate Hypersensitivity 03/2016 - 09/2013
4	Neoplasms (Cancer) 11/2020 - 01/2014
3	Exanthema (Rash) 10/2021 - 01/2016
3	Dermatitis 01/2019 - 11/2006
3	Infections 01/2017 - 11/2011
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 10/2021
2	Back Pain (Backache) 01/2021 - 07/2014
2	Flushing 10/2020 - 07/2014
2	Wounds and Injuries (Trauma) 10/2020 - 11/2011
2	Chronic Urticaria 01/2019 - 01/2015
2	Injection Site Reaction 11/2018 - 01/2018
2	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 06/2009
2	Pneumonia (Pneumonitis) 07/2016 - 01/2015
2	Delayed Hypersensitivity (Hypersensitivity, Type IV) 03/2016 - 03/2016
2	Eosinophilia 01/2016 - 11/2006
1	Abdominal Pain (Pain, Abdominal) 01/2021
1	Diarrhea 01/2021
1	Vomiting 01/2021
1	Breast Neoplasms (Breast Cancer) 11/2020
1	Pruritus (Itching) 10/2020
1	Surgical Wound Infection 01/2020
1	Rare Diseases (Rare Disease) 02/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2019
1	Hereditary Angioedema Types I and II 11/2018
1	Dizziness (Lightheadedness) 11/2018
1	Disease Progression 07/2018

Drug/Important Bio-Agent (IBA)

16	Pharmaceutical PreparationsIBA 01/2021 - 01/2008
10	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2008
9	COVID-19 VaccinesIBA 07/2022 - 01/2021
9	Penicillins (Penicillin)FDA Link 01/2021 - 05/2014
8	lanadelumabIBA 01/2022 - 01/2017
7	Carboplatin (JM8)FDA LinkGeneric 11/2017 - 06/2009
7	Epinephrine (Adrenaline)FDA LinkGeneric 08/2013 - 11/2007
6	Messenger RNA (mRNA)IBA 07/2022 - 01/2021
6	VaccinesIBA 01/2022 - 01/2021
5	Plasma KallikreinIBA 01/2021 - 01/2017
5	Cephalosporins (Cephalosporin Antibiotics)IBA 10/2020 - 07/2014
5	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 02/2019 - 01/2009
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2017 - 01/2008
4	PlatinumIBA 11/2017 - 06/2009
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 07/2014
3	Vancomycin FDA LinkGeneric 12/2021 - 11/2015
3	LactamsIBA 12/2021 - 10/2015
3	beta-LactamsIBA 01/2021 - 07/2016
3	mRNA VaccinesIBA 01/2021 - 01/2021
3	Kallikreins (Kallikrein)IBA 02/2019 - 09/2010
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2017 - 01/2014
3	icatibantIBA 07/2017 - 08/2010
3	BradykininIBA 01/2017 - 09/2010
3	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2016 - 04/2010
3	Histamine Antagonists (Antihistamines)IBA 07/2010 - 07/2007
2	AllergensIBA 10/2021 - 08/2007
2	AndrogensIBA 11/2020 - 01/2008
2	Cefazolin (Ancef)FDA LinkGeneric 01/2020 - 06/2014
2	KininsIBA 02/2019 - 09/2010
2	Monoclonal AntibodiesIBA 11/2018 - 01/2017
2	Immunoglobulin E (IgE)IBA 05/2018 - 05/2014
2	Ceftaroline FDA Link 07/2016 - 01/2015
2	Proton Pump InhibitorsIBA 03/2016 - 12/2013
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2015 - 01/2008
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2015 - 01/2008
2	Vitamin D FDA LinkGeneric 04/2010 - 02/2008
1	AntibodiesIBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Docetaxel (Taxotere)FDA Link 01/2022
1	Opioid Analgesics (Opioids)IBA 12/2021
1	Contrast MediaIBA 12/2021
1	iso-sulfan blue (Lymphazurin)FDA LinkGeneric 10/2021
1	ibrutinibIBA 10/2021
1	Methylprednisolone FDA LinkGeneric 01/2021
1	Polysorbates (PSML)FDA Link 01/2021
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2021
1	berotralstatIBA 01/2021
1	Tryptases (Tryptase)IBA 01/2021
1	Excipients (Suspending Agents)IBA 01/2021
1	polyethylene glycol 3350 (miralax)FDA LinkGeneric 01/2021
1	beta Lactam AntibioticsIBA 01/2021
1	SulfonamidesIBA 10/2020
1	Amoxicillin (Wymox)FDA LinkGeneric 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2019

Therapy/Procedure

22	Therapeutics 03/2022 - 01/2007
5	Drug Therapy (Chemotherapy) 10/2020 - 11/2015
3	Injections 10/2021 - 01/2021
3	Anesthesia 01/2021 - 01/2015
1	Cesarean Section (Caesarean Section) 01/2021
1	Contraindications 01/2021
1	Oral Hygiene (Dental Hygiene) 10/2020
1	Dental Care 10/2020
1	Antibiotic Prophylaxis 01/2020
1	Preoperative Care 01/2020